Cytox – a UK-based company with a unique scientific and proprietary technology platform that is helping to elucidate the biology behind dementia risk. Our focus is on development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Potential Applications

A clear need for less expensive, more readily accessible tests for Alzheimer’s disease…

more

Our Expert Team

An experienced scientific and commercial team working together to develop prognostic tests for cognitive decline and the risk of developing AD or other dementias…

more

Science & Technology

Cell cycle dysfunction is an important field with the potential to yield new tools to aid our understanding of AD and dementia development…

more

Latest News

Cytox to present at Master Investors 2014…

more

Socials

Connect with Cytox!

Register

Register here to receive the latest news and updates as our clinical plans accelerate during 2014

Back to Top